Emerging infectious diseases in voluntary blood donors in parts of China: Based on metagenomics analysis
- VernacularTitle:基于中国部分地区无偿献血人群宏基因组学的新发病原体分析
- Author:
Yuhui LI
1
,
2
;
Zhan GAO
1
;
Shilin LI
1
;
Yujia LI
1
;
Yang HUANG
1
;
Limin CHEN
1
;
Mei HUANG
3
;
Jianhua WAN
4
;
Weilan HE
5
;
Wei MAO
6
;
Jie CAI
7
;
Jingyu ZHOU
8
;
Ru YANG
9
;
Yijing YIN
10
;
Yanli GUO
11
;
Miao HE
1
Author Information
- Publication Type:Journal Article
- Keywords: emerging pathogens; voluntary blood donors; China; metagenomics; high-throughput sequencing; emerging infectious diseases; bioinformatics
- From: Chinese Journal of Blood Transfusion 2021;34(5):440-446
- CountryChina
- Language:Chinese
- Abstract: 【Objective】 To analyze the metagenomics and microbiology of voluntary blood donors in China, so as to assess the potential threats of emerging infectious diseases to the safety of blood transfusion. 【Methods】 12 300 plasma samples (10 mL each) collected by central blood stations in Chongqing, Liuzhou, Urumqi, Mianyang, Wuhan, Nanjing, Mudanjiang, and Dehong Prefecture area from 2012 to 2018 were subjected to total DNA extraction after ultracentrifugation (32 000 rpm/min, centrifugal radius 91.9 mm) in minipools of 160 donations. The metagenomic library was constructed, and deep sequencing was conducted by Illumina Hiseq 4 500. By comparing with reference sequences of bacteria, fungi, parasites and viruses, metagenomic data were analyzed, classification of microbes were identified, and potentially harmful pathogens were evaluated. 【Results】 A total of 632 GB clean data were obtained by deep sequencing, and the top three pathogens were Pseudomonas(0.561 1%), Burkholderia(0.468 7%) and Serratia(4.242 0%). Pathogens with potential threat which could be transmitted by blood transfusion or blood products were found, such as human parvovirus B19(0.126 6%), Leishmania spp(1.348 5%) and Toxoplasma gondii(0.615 8%). 【Conclusion】 Our study analyzed metagenomics of voluntary blood donors in parts of China and revealed pathogens that may cause potential harm to blood safety, which were helpful for targeted prevention and control of emerging infectious diseases.